Trial intelligence / Profile preview

SALT: ATV/r + 3TC Maintenance in HIV-1

NCT01307488Phase 4Completed

Sponsor
Fundación SEIMC-GeSIDA
Start
Sep 2011
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atazanavir, ritonavir, lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Fundación SEIMC-GeSIDA. Started Sep 2011; status: completed.

02

Drugs

atazanavirritonavirlamivudine
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT01307488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01307488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call